Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease

NS3/4A protease is an important emerging target for the cure of hepatitis C. There are many inhibitors of HCV NS3/4A protease that are passing through the clinical improvement indicating momentous reduction in the viral infection rate of patients. In this study molecular docking via MOE-Dock program...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadood, Abdul, Riaz, Muhammad, Jamal, Syed Babar, Shah, Masaud, Lodhi, Muhammad Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2013
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607190/
https://www.ncbi.nlm.nih.gov/pubmed/23559750
http://dx.doi.org/10.6026/97320630009309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607190/
https://www.ncbi.nlm.nih.gov/pubmed/23559750
http://dx.doi.org/10.6026/97320630009309

Ejemplares similares